Brief: Sequana Medical Announces Initial Positive Data From MOJAVE

Sequana Medical NV

18/10/2023 06:08

Oct 18 (Reuters) - Sequana Medical NV  SEQUA.BR :
    * SEQUANA MEDICAL ANNOUNCES INITIAL POSITIVE DATA FROM
MOJAVE, A
US PHASE 1/2A STUDY OF DSR® 2.0 FOR TREATMENT OF HEART FAILURE
THROUGH BREAKING VICIOUS CYCLE OF CARDIORENAL SYNDROME
    * WE ARE CONFIDENT THAT AFTER THIRD PATIENT IS TREATED AND
BASED
ON THESE FAVORABLE RESULTS, MULTI-CENTRIC ROLL-OUT IN Q1 2024
WILL START AS PLANNED

Source text for Eikon:  ID:nGNE4HZ2F2 
Further company coverage:  SEQUA.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))